Condition

Persistent, Recurrent, or Metastatic Cervical Cancer clinical trials and research

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• Low-dose Pembrolizumab with Chemotherapy for Advanced Cervical Cancer

  This study is testing if a low dose of pembrolizumab combined with chemotherapy can help women with advanced cervical cancer who can't have curative treatments feel better.

  Recruiting Phase 2 Instituto Nacional de Cancer, Brazil · Rio de Janeiro, Rio de Janeiro · NCT06670911

• GLS-010 plus platinum chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer

  This phase 3 trial tests whether adding GLS-010 to standard platinum-based chemotherapy, with or without bevacizumab, can improve outcomes as first-line treatment for persistent, recurrent, or metastatic cervical cancer.

  Recruiting Phase 3 Guangzhou Gloria Biosciences Co., Ltd. · Shanghai, Shanghai Municipality · NCT05798819

Related topics

Quick answers

How many Persistent, Recurrent, or Metastatic Cervical Cancer clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (1 trial), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →